undamentalytics Newsletter
Sign in

Adapthealth Corp. cash flow statement

In fiscal 2025, Adapthealth Corp.'s operations generated $602m of cash; it spent $382m on capital projects, leaving free cash flow of $219m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations6860196276374481542602583
Depreciation and amortisation486382258351383365382409
Stock-based pay11119252222152222
Capital spending102140203391337306382486
Free cash flow583915672−1814323621998
Free cash flow after stock pay582813747−4012122119875
Share buybacks—2000142900—
Shares issued—12514327900———

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: AHCO vs AMNAHCO vs ASTHAHCO vs CHE

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Adapthealth Corp.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Adapthealth Corp.